In addition, we found that high expression of EYA1 in ccRCC patients was significantly associated with clinicopathological parameters, including pathological stage, tumor grade, shorter OS, and PFI (progress free interval). The gene discussed is EYA1; the disease is nonpapillary renal cell carcinoma.